Sarkissian, Sarkis – Trademark Portfolio

Entity Type: 01

Sarkissian, Sarkis holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 4 filings in this category. The portfolio also extends into Class 43 (Hotels & Restaurants) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include THE WORLD'S MOST BEAUTIFUL FLOWERS. The owner is based in Glendale, CA.

Suite C

Glendale, CA 91204

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Sarkissian, Sarkis's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

31
Natural Agricultural Products (4 filings)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

43
Hotels & Restaurants (1 filing)

Services for providing food and drink; temporary accommodation

Frequently Asked Questions

How many trademarks does Sarkissian, Sarkis have?

Sarkissian, Sarkis has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned.

What trademark classes does Sarkissian, Sarkis file in?

Sarkissian, Sarkis files trademarks across 2 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 43 (Hotels & Restaurants). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.

What are Sarkissian, Sarkis's most well-known trademarks?

Sarkissian, Sarkis's registered trademark portfolio includes well-known marks such as THE WORLD'S MOST BEAUTIFUL FLOWERS. These are among 2 currently registered trademarks in the portfolio.

What is Sarkissian, Sarkis's trademark registration success rate?

Sarkissian, Sarkis has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.